Hexagon Nutrition IPO
Price Band
₹42 – ₹45
Issue Size
₹138.87 Cr
Lot Size
333 shares
Min ₹14,985
Issue Dates
5 Jun – 9 Jun 2026
Listing Date
12 Jun 2026
About Hexagon Nutrition Ltd.
Hexagon Nutrition Ltd. is a research-driven nutrition company focused on improving health outcomes through scientifically formulated nutrition products. Incorporated in 1993, the company has built strong capabilities in the development and manufacturing of micronutrient premixes, clinical nutrition solutions, therapeutic formulations, and ready-to-use foods. It operates at the intersection of healthcare, wellness, and food technology, addressing nutritional deficiencies and supporting preventive healthcare across diverse population segments. The company’s product portfolio is broadly divided into three segments: branded wellness and clinical nutrition (B2C), premix formulations (B2B/B2B2C), and ready-to-use foods and micronutrient powders. Its B2C segment includes products such as protein supplements, pediatric nutrition, weight management solutions, and disease-specific formulations sold under brands like Pentasure, Obesigo, Pediagold, and Nutrone. These products are widely distributed through pharmacies, hospitals, online platforms, and its own digital channels, enabling broad accessibility to consumers. In the B2B and B2B2C segments, Hexagon Nutrition collaborates with food and pharmaceutical companies by supplying customized micronutrient premixes and fortification solutions. These premixes are essential for enhancing the nutritional value of staple foods and processed products. The company also plays a significant role in public health and ESG initiatives through its Ready-to-Use Foods (RUFs) and Micronutrient Powders (MNPs), which are designed to combat malnutrition, particularly in developing regions. Hexagon Nutrition operates a well-established manufacturing infrastructure with facilities located in Nasik, Chennai, and Thoothukudi in India, along with an international manufacturing unit in Tashkent, Uzbekistan. The facilities in Chennai and Thoothukudi are located in Special Economic Zones (SEZs), offering advantages such as proximity to ports and duty benefits on imports and exports. This strategic manufacturing footprint enables efficient production, cost optimization, and seamless supply chain operations for both domestic and global markets. The company has a strong global presence, exporting its products to over 75 countries across Asia, Africa, Europe, and South America. It has set up international offices in South Africa, Uzbekistan, and Hong Kong to strengthen its export operations and global partnerships. Domestically, the company has developed an extensive distribution network comprising over 350 distributors, including several with multi-state presence, ensuring deep market penetration across India. A key strength of Hexagon Nutrition lies in its dedicated focus on research and development. The company operates in-house R&D facilities in Nasik and Chennai, supported by a team of qualified professionals specializing in nutrition science and formulation development. This emphasis on innovation enables the company to continuously introduce new products, adapt to evolving consumer needs, and maintain compliance with international quality standards, positioning it as a competitive player in the global nutrition and healthcare industry.
Visit WebsiteIPO Details
| Price Band | ₹42 – ₹45 |
| Face Value | ₹1 |
| Lot Size | 333 shares(Min ₹14,985) |
| Issue Size | ₹138.87 Cr |
| Fresh Issue | TBA |
| Offer for Sale | ₹138.87 Cr |
| Total Shares Offered | 3,08,59,704 |
| Listed On | Both |
Objects of the Issue
The IPO is entirely an Offer for Sale (OFS). The company will not receive any proceeds from the issue. All proceeds will go to the selling shareholders.
Key Financial Metrics
EPS (Basic)
₹2.93
P/E Ratio
15.35x
ROE
13.02%
ROCE
14.82%
Debt / Equity
0.18
Financial Performance
| Particulars (₹ Cr) | FY2023 | FY2024 | FY2025 | 9M FY2026 |
|---|---|---|---|---|
| Revenue | 281.65 | 304.62 | 331.29 | 275.57 |
| EBITDA | 17.17 | 24.88 | 40.07 | 37.55 |
| PAT | 5.82 | 12.21 | 24.38 | 27.03 |
| Total Assets | 288.9 | 250.54 | 261.36 | 327.6 |
| Net Worth | 163.84 | 176.29 | 195.6 | 223.05 |
| Total Borrowings | 51.87 | 36.89 | 26.6 | 39.79 |
Valuation
Market Capitalisation
P/E Ratio
Promoter Holding
Public Holding
Lot Size & Allocation
Investment by Category
| Category | Lot Size | Min Investment | Max Investment |
|---|---|---|---|
| Retail (RII) | 333 shares | ₹14,985 | ₹1,94,805 |
| S-HNI | 14 × 333 | ₹2,09,790 | ₹9,89,010 |
| B-HNI | 67 × 333 | ₹10,03,995 | — |
Reservation / Allocation
| Category | Allocation | Cut-off |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 50% | Yes |
| NII (Non-Institutional Investors) | 15% | No |
| RII (Retail Individual Investors) | 35% | Yes |
Registrar & Lead Managers
Registrar
Lead Managers (2)
Peer Comparison
| Company | Listed | Mkt Cap (₹ Cr) | EPS (₹) | P/E | ROE % |
|---|---|---|---|---|---|
| Hexagon Nutrition IPO (this IPO) | — | 553.13 | ₹2.93 | 15.35x | 13.02% |
| Abbott India Ltd | Yes | — | — | — | — |
| Nestle India Ltd | Yes | — | — | — | — |
| Zydus Lifesciences Ltd | Yes | — | — | — | — |
| GlaxoSmithKline Pharmaceuticals Ltd | Yes | — | — | — | — |
Data as of 31/3/2025
Frequently Asked Questions
8 questions about Hexagon Nutrition IPO IPO
Important Dates
Community Discussion
Ask questions and share your thoughts about this IPO
Be the first to ask or share about Hexagon Nutrition IPO